Stephanie Van De Wall, Ph.D.
Stephanie van de Wall, Ph.D.

Postdoctoral Research Scholar  

Department of Microbiology and Immunology
3-501 Bowen Science Building
51 Newton Road
University of Iowa
Iowa City, IA 52242-1109

Lab: 319-335-9919
Fax: 319-335-9006


2018: Ph.D., Department of Medical Microbiology, Tumor Virology and Cancer Immunotherapy, University of Groningen, Groningen, The Netherlands
2011: M.A., Infection and Immunity Program, Utrecht University, Utrecht, The Netherlands
2009: B.A., Biomedical Sciences, Specialization in Infectious Diseases, University of Edinburgh, Edinburgh, Scotland


Immunity to influenza virus: Myeloid-T cell interactions in the lung

Publications Pubmed

  1. Singh, A., Koutsoumpli, G., van de Wall, S., & Daemen, T. (2019). An alphavirus-based therapeutic cancer vaccine: from design to clinical trial. Cancer Immunol Immunother, 68(5), 849-859.  DOI: 10.1007/s00262-018-2276-z
  2. van de Wall, S., Ljungberg, K., Ip, P. P., Boerma, A., Knudsen, M. L., Nijman, H. W., Daemen, T. (2018). Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens. Oncoimmunology, 7(10), e1487913. doi:10.1080/2162402x.2018.1487913 PMCID: PMC6169581
  3. Hartimath, S. V., Draghiciu, O., van de Wall, S., Manuelli, V., Dierckx, R. A., Nijman, H. W., de Vries, E. F. (2017). Noninvasive monitoring of cancer therapy induced activated T cells using [(18)F]FB-IL-2 PET imaging. Oncoimmunology, 6(1), e1248014. doi:10.1080/2162402x.2016.1248014 PMCID: PMC5283633
  4. Komdeur, F. L., Prins, T. M., van de Wall, S., Plat, A., Wisman, G. B. A., Hollema, H., Nijman, H. W. (2017). CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer. Oncoimmunology, 6(9), e1338230. doi:10.1080/2162402x.2017.1338230 PMCID: PMC559908
  5. van de Wall, S., Walczak, M., van Rooij, N., Hoogeboom, B. N., Meijerhof, T., Nijman, H. W., & Daemen, T. (2015). Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7. Vaccines (Basel), 3(2), 221-238. doi:10.3390/vaccines3020221 PMCID: PMC4494346
  6. van de Wall, S., Nijman, H. W., & Daemen, T. (2014). HPV-specific immunotherapy: key role for immunomodulators. Anticancer Agents Med Chem, 14(2), 265-279. DOI : 10.2174/187152061402140128163306